Pfizer/Warner-Lambert Merger Talks Begin: AHP Vows To Press On
The merger negotiations between Warner-Lambert and Pfizer are likely to focus on the $1 bil. gap between Pfizer's offer and Warner's current stock market valuation.
The merger negotiations between Warner-Lambert and Pfizer are likely to focus on the $1 bil. gap between Pfizer's offer and Warner's current stock market valuation.